Litcius/Paper detail

PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer

Haiying Zhu, Chengyong Du, Meng Yuan, Peifen Fu, Qiaojun He, Bo Yang, Ji Cao

2020Drug Discovery Today34 citationsDOI

Topics & Concepts

Triple-negative breast cancerBreast cancerImmunotherapyAdjuvantMedicineTumor microenvironmentPD-L1Immune systemCancer researchChemotherapyCancerOncologyCancer immunotherapyImmunologyInternal medicineCancer Immunotherapy and BiomarkersAdvanced Breast Cancer TherapiesImmunotherapy and Immune Responses
PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer | Litcius